Papers: 10.3389/fonc.2021.575457

https://doi.org/10.3389/fonc.2021.575457

Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials

Cited by: 4
Author(s): Leyin Zhang, Leitao Sun, Yiwen Zhou, Jinping Yu, Yuan-Hsiang Lin, Harpreet Wasan, Minhe Shen, Shanming Ruan
Published: over 5 years ago

Software Mentions 1